Radon Biomonitoring and microRNA in Lung Cancer

Int J Mol Sci. 2020 Mar 20;21(6):2154. doi: 10.3390/ijms21062154.

Abstract

Radon is the number one cause of lung cancer in non-smokers. microRNA expression in human bronchial epithelium cells is altered by radon, with particular reference to upregulation of miR-16, miR-15, miR-23, miR-19, miR-125, and downregulation of let-7, miR-194, miR-373, miR-124, miR-146, miR-369, and miR-652. These alterations alter cell cycle, oxidative stress, inflammation, oncogene suppression, and malignant transformation. Also DNA methylation is altered as a consequence of miR-29 modification induced by radon. Indeed miR-29 targets DNA methyltransferases causing inhibition of CpG sites methylation. Massive microRNA dysregulation occurs in the lung due to radon expose and is functionally related with the resulting lung damage. However, in humans this massive lung microRNA alterations only barely reflect onto blood microRNAs. Indeed, blood miR-19 was not found altered in radon-exposed subjects. Thus, microRNAs are massively dysregulated in experimental models of radon lung carcinogenesis. In humans these events are initially adaptive being aimed at inhibiting neoplastic transformation. Only in case of long-term exposure to radon, microRNA alterations lead towards cancer development. Accordingly, it is difficult in human to establish a microRNA signature reflecting radon exposure. Additional studies are required to understand the role of microRNAs in pathogenesis of radon-induced lung cancer.

Keywords: biomonitoring; lung cancer; microRNA; radon.

Publication types

  • Review

MeSH terms

  • Animals
  • Biological Monitoring*
  • Epigenesis, Genetic
  • Humans
  • Lung Neoplasms / epidemiology
  • Lung Neoplasms / genetics*
  • MicroRNAs / genetics*
  • MicroRNAs / metabolism
  • Radiation Exposure / adverse effects
  • Radon / metabolism*

Substances

  • MicroRNAs
  • Radon